The effect of the population-based cervical cancer screening program on 5-year survival in cervical cancer patients in Lower Silesia.


Journal

Advances in clinical and experimental medicine : official organ Wroclaw Medical University
ISSN: 1899-5276
Titre abrégé: Adv Clin Exp Med
Pays: Poland
ID NLM: 101138582

Informations de publication

Date de publication:
Oct 2019
Historique:
pubmed: 23 10 2019
medline: 13 11 2019
entrez: 23 10 2019
Statut: ppublish

Résumé

Poland is considered among the European countries with an average incidence of cervical cancer (CC; about 3,000-3,500/year) and at the same time with high mortality (5-year survival rate - 55.2%). For this reason, in 2006 Poland introduced a Population-Based Cervical Cancer Prevention and Early Detection Program addressed to women aged 25-59 years, in which a cytological test is carried out every 3 years. The aim of the study was to assess the changes in the curability of CC patients brought by the introduction of the Screening Program in the Lower Silesian voivodeship and to identify the subpopulation of women for whom activities aimed at increasing adherence rates must be intensified. The 5-year relative survival in 3,586 CC patients from 2000-2010 registered in the Lower Silesian Cancer Registry was analyzed. In the Lower Silesian voivodeship, a 55.1% 5-year survival rate was recorded in 2000-2004 and 70.5% in 2010. The highest increase in 5-year relative survival rates was found in rural communities (from 53.1% in 2000-2004 to 77.7% in 2010) and in Wrocław (56.8% and 74.2%, respectively). In the study group, the number of patients with invasive CC (C53) detected in the local stage of the disease increased systematically from 61.5% in 2000-2004 to 74.3% in 2010. The introduction of the population-based screening program improved the curability rate in CC patients in the Lower Silesian voivodeship. In order to maintain the recent positive trends, further education should be continued, and activities aimed at increasing adherence to screening tests should be intensified, especially in urban-rural communities.

Sections du résumé

BACKGROUND BACKGROUND
Poland is considered among the European countries with an average incidence of cervical cancer (CC; about 3,000-3,500/year) and at the same time with high mortality (5-year survival rate - 55.2%). For this reason, in 2006 Poland introduced a Population-Based Cervical Cancer Prevention and Early Detection Program addressed to women aged 25-59 years, in which a cytological test is carried out every 3 years.
OBJECTIVES OBJECTIVE
The aim of the study was to assess the changes in the curability of CC patients brought by the introduction of the Screening Program in the Lower Silesian voivodeship and to identify the subpopulation of women for whom activities aimed at increasing adherence rates must be intensified.
MATERIAL AND METHODS METHODS
The 5-year relative survival in 3,586 CC patients from 2000-2010 registered in the Lower Silesian Cancer Registry was analyzed.
RESULTS RESULTS
In the Lower Silesian voivodeship, a 55.1% 5-year survival rate was recorded in 2000-2004 and 70.5% in 2010. The highest increase in 5-year relative survival rates was found in rural communities (from 53.1% in 2000-2004 to 77.7% in 2010) and in Wrocław (56.8% and 74.2%, respectively). In the study group, the number of patients with invasive CC (C53) detected in the local stage of the disease increased systematically from 61.5% in 2000-2004 to 74.3% in 2010.
CONCLUSIONS CONCLUSIONS
The introduction of the population-based screening program improved the curability rate in CC patients in the Lower Silesian voivodeship. In order to maintain the recent positive trends, further education should be continued, and activities aimed at increasing adherence to screening tests should be intensified, especially in urban-rural communities.

Identifiants

pubmed: 31638746
doi: 10.17219/acem/109759
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1377-1383

Auteurs

Dominika Zielecka-Dębska (D)

Radiotherapy Department, Lower Silesian Oncology Centre in Wrocław, Poland.
Department of Oncology, Faculty of Medicine, Wroclaw Medical University, Poland.

Jerzy Błaszczyk (J)

Department of Epidemiology and Lower Silesian Cancer Registry, Lower Silesian Oncology Centre in Wrocław, Poland.

Dawid Błaszczyk (D)

Lower Silesian Coordinating Center for Preventive Programs, Lower Silesian Oncology Centre in Wrocław, Poland.

Jolanta Szelachowska (J)

Radiotherapy Department, Lower Silesian Oncology Centre in Wrocław, Poland.
Department of Oncology, Faculty of Medicine, Wroclaw Medical University, Poland.

Krystian Lichoń (K)

Radiotherapy Department, Lower Silesian Oncology Centre in Wrocław, Poland.
Department of Oncology, Faculty of Medicine, Wroclaw Medical University, Poland.

Adam Maciejczyk (A)

Radiotherapy Department, Lower Silesian Oncology Centre in Wrocław, Poland.
Department of Oncology, Faculty of Medicine, Wroclaw Medical University, Poland.

Rafał Matkowski (R)

Breast Unit, Lower Silesian Oncology Centre in Wrocław, Poland.
Department of Oncology, Faculty of Medicine, Wroclaw Medical University, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH